Abstract
To estimate the magnitude of benefit of chemotherapy in prolonging survival for patients with metastatic colorectal cancer, a meta-analysis of randomized controlled trial was performed. A systematic search was performed to identify randomized trials comparing chemotherapy with observation or supportive care alone. Trials were assessed for quality of reporting, publication bias and heterogeneity. Relative risks for outcomes from published data were pooled using a random-effects model. Seven trials with 614 patients were included. All trials used fluoropyrimidine-based chemotherapy, through a variety of routes and schedules, including intravenous, intra-portal and hepatic arterial infusion. Compared with the ‘no-chemotherapy’ arm, chemotherapy significantly reduced 1-year mortality (risk ratio 0.69; 95% confidence interval (CI) 0.60–0.81, P< 0.00001). The mortality at 2 years was not significantly different (risk ratio 0.93; 95% CI 0.87–1.00, P = 0.053). Between-trial comparisons demonstrated benefit with a variety of routes and schedules. Chemotherapy significantly prolongs 1-year survival for patients with metastatic colorectal cancer, and should be offered to those with good performance status. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Advanced Colorectal Cancer Meta-analysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10: 896–903
Allen-Mersh TG, Eatlam S, Fordy C, Abrams K and Houghton J (1994) Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344: 1255–1260
Beretta G, Bollina R, Labianca E, Arnoldi E, Luliri P and Matignoni G (1994) A controlled study of supportive care versus supportive care plus 5-fluorouracil/folinic acid for advanced metastatic gastrointestinal carcinomas in the elderly patient. Proc Ann Meet Am Soc Clin Oncol 13: 221
Cohen AM, Minsky BD and Schilsky RL (1997). The Principles and Practice of Clinical Oncology, Devita V1177 Lippincott-Raven: Philadelphia
Cunningham D, Pyrhonen S, James RD, Punt CJ, Hickish TF, Heikkila R, Johannesen TB, Starkhammar H, Topham CA, Awad L, Jacques C and Herait P (1998) Randomized trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352: 1413–1418
DerSimonian R and Laird NM (1986) Meta-analysis in clinical trials. Controlled Clin Trials 7: 177–188
Fleiss JL (1981). Statistical Methods for Rates and Proportions, 161–165, J Wiley: New York
Foster HJH and Berman MM (1977) Solid liver tumours. Major Problems in Clinical Surgery 22, Ebert PA209–234, WB Saunders: Philadelphia, PA
Glimelius B, Hoffman K, Graf W, Haglund U, Nyren O, Pahlman L and Sjoden PO (1995) Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol 6: 269–274
Hafstrom L, Engaras B, Holmberg S, Gustavsson B, Jonsson PE, Lindner P, Naredi P and Tidebrant G (1994) Treatment of liver metastases from colorectal cancer with hepatic arterial occlusion, intraportal 5-fluorouracil infusion, and allopurinol. Cancer 74: 2749–2756
Hine KR and Dykes PW (1984) Prospective randomized trial of early cytotoxic therapy for recurrent colorectal carcinoma detected by serum CEA. Gut 25: 682–688
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ and McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clin Trial 17: 1–12
Lau J, Ioannidis JPA and Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Int Med 127: 820–826
Meta-analysis Group in Cancer (1998) Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16: 301–308
National Cancer Institute of Canada (1997). Canadian Cancer Statistics, NCIC: Toronto, Canada
Nordic Gastrointestinal Tumour Adjuvant Therapy Group (1992) Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 10: 904–911
Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, Salmon R, Julien M, Roullet Audy JC, Gallot D, Gouzi JL, Pailler JL, Elisa D, Lacaine F, Roos S, Rotman N, Luboinski M and Lasser P (1992) Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long term results of a prospective randomized trial. J Clin Oncol 10: 1112–1118
Scheithauer W, Rosen H, Kornek GV, Sebesta C and Depisch D (1993) Randomized comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. Br Med J 306: 752–755
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Jonker, D., Maroun, J. & Kocha, W. Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials. Br J Cancer 82, 1789–1794 (2000). https://doi.org/10.1054/bjoc.1999.1254
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1254
Keywords
This article is cited by
-
Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells
Journal of Experimental & Clinical Cancer Research (2019)
-
Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under Therapy
CardioVascular and Interventional Radiology (2017)
-
Preoperative Imaging in Colorectal Liver Metastases: Current Practices
Current Surgery Reports (2014)
-
Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades
British Journal of Cancer (2013)
-
Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer
Investigational New Drugs (2011)